BioLife Solutions Inc (BLFS)

Financial leverage ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total assets	US$ in thousands	399,487	381,652	374,976	401,602	412,714	411,152	433,177	446,470	450,229	488,020	470,681	544,279	554,286	559,391	520,969	240,024	234,829	195,887	113,970	94,987
Total stockholders’ equity	US$ in thousands	348,909	325,461	321,442	333,405	337,663	332,017	352,128	358,107	364,188	405,120	409,544	476,075	478,047	489,259	452,281	208,777	204,429	186,851	105,843	67,709
Financial leverage ratio		1.14	1.17	1.17	1.20	1.22	1.24	1.23	1.25	1.24	1.20	1.15	1.14	1.16	1.14	1.15	1.15	1.15	1.05	1.08	1.40

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $399,487K ÷ $348,909K
= 1.14

The financial leverage ratio of BioLife Solutions Inc has fluctuated over the past few years, ranging from a low of 1.05 in September 30, 2020, to a high of 1.25 in March 31, 2023. The financial leverage ratio measures the proportion of the company's debt to its equity, indicating how much the company relies on debt financing.

In general, a higher financial leverage ratio suggests higher financial risk, as the company has more debt relative to its equity. Conversely, a lower ratio indicates a more conservative financial structure.

BioLife Solutions Inc's financial leverage ratio has shown some variability, with the highest levels recorded in the most recent periods, reaching 1.24 in September 30, 2022, and December 31, 2022. This could indicate a shift towards a more debt-heavy capital structure during that period, which may potentially increase the company's financial risk.

It would be important for stakeholders to monitor these trends closely to assess the company's financial health and ability to manage its debt obligations effectively.